Safety analysis of the French Intergroup R98 trial comparing 5FU-leucovorin alone or with irinotecan in resected stages II-III rectal cancers

Authors :: Ph. Rougier
J.-Y. Douillard
Olivier Dupuis
Ayman Zawadi
Pascal Piedbois
Roger Faroux
E. Quinaux
Veronique Guerin-Meyer
T. Andre
M. Ychou
Source :: Journal of Clinical Oncology. 26:4088-4088
Publication Year :: 2008
Publisher :: American Society of Clinical Oncology (ASCO), 2008.
Abstract: 4088 Background: Irinotecan combined with 5FU/LV improves the outcome of patients (pts) with advanced colorectal cancer. R98 trial tests the hypothesis that this combination is superior to 5FU/LV a...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Surgery
Irinotecan
Advanced colorectal cancer
stomatognathic diseases
Internal medicine
medicine
5FU/Leucovorin
business
medicine.drug

Tools